Arrowhead Pharmaceuticals, Inc. KOL Event (Virtual) Transcript
Good morning, everyone, and welcome to the Arrowhead Pharmaceuticals investor webcast. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Arrowhead website following the conclusion of the event.
I'd now like to turn the call over to Vince Anzalone, Senior Vice President of Finance and Investor Relations at Arrowhead Pharmaceuticals. Please go ahead, Vince.
Thank you, Tara, and thanks, everybody, for joining us today. We're excited to present the data that we presented yesterday at the European Society of Cardiology in Munich for what we think is groundbreaking data from the SHASTA-3 and 4 studies of plozasiran.
So before we start, I just want to make sure everybody knows that we will be making forward-looking statements today, so refer to our SEC filings for risk factors. I also want to remind people that the SHTG indication has not been viewed or approved by any regulatory authorities around the world, so it
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
